FindTrial
Sign In

Risk prediction model based on D-dimer, Fibrinogen and tumor-related markers for screening gynecological malignant tumors

Risk prediction model based on D-dimer, Fibrinogen and tumor-related markers for screening gynecological malignant tumors

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023149
Enrollment
Unknown
Registered
2019-05-13
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological malignant tumors

Interventions

Gold Standard:Histopathological examination
Index test:D-dimer,&#32
Fibrinogen&#32
and&#32
tumor-related&#32
markers

Sponsors

Nanjing Maternity and Child Health Care hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Surgical treatment for the first time; 2. Patient with gynecological malignant tumors (cervical cancer, endometrial cancer, ovarian malignant tumors) and confirmed by pathological examination.

Exclusion criteria

Exclusion criteria: 1. The subjects had abnormal coagulation function; 2. Abnormal liver function; 3. Patients with poor control of blood sugar or blood pressure.

Design outcomes

Primary

MeasureTime frame
SPE, SEN, ACC, ROC;—

Countries

China

Contacts

Public ContactLiu Guangquan

Nanjing Maternity and Child Health Care hospital

w467205559@126.com+86 18994080535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026